PROMISCUOUS AND ALLELE-SPECIFIC ANCHORS IN HLA-DR-BINDING PEPTIDES

被引:367
|
作者
HAMMER, J
VALSASNINI, P
TOLBA, K
BOLIN, D
HIGELIN, J
TAKACS, B
SINIGAGLIA, F
机构
[1] F HOFFMANN LA ROCHE & CO LTD, DEPT PHARMACEUT RES NEW TECHNOL, CH-4002 BASEL, SWITZERLAND
[2] F HOFFMANN LA ROCHE & CO LTD, DEPT INFLAMMAT & AUTOIMMUNE DIS, CH-4002 BASEL, SWITZERLAND
关键词
D O I
10.1016/0092-8674(93)90306-B
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The major histocompatibility complex (MHC) class II molecules are highly polymorphic membrane glycoproteins that bind peptide fragments of proteins and display them for recognition by CD4+ T cells. To understand the effect of human MHC class II polymorphism on peptide-MHC interaction, we have isolated M13 phage from a large M13 peptide display library by selection with DRB1*0401 and DRB1*1101 molecules, as recently described for DRB1*0101. Sequence analysis of the peptide-encoding region of DR-bound phage led to the identification of position-specific anchor residues, defining motifs for peptide binding to DR molecules. The three DR motifs share two anchor residues at relative positions 1 and 4, while allele-specific anchor residues have been identified at position 6. These results provide a biophysical basis for both the promiscuity and the specificity of peptide recognition by DR molecules.
引用
收藏
页码:197 / 203
页数:7
相关论文
共 50 条
  • [41] Identification of HLA-Cw6.02 and HLA-Cw7.01 allele-specific binding motifs by screening synthetic peptide libraries
    Dionne, SO
    Lake, DF
    Grimes, WJ
    Smith, MH
    IMMUNOGENETICS, 2004, 56 (06) : 391 - 398
  • [42] Small molecules trigger peptide loading of HLA-DR by allele-specific induction of a peptide-receptive state.
    Kramer, H
    Dickhaut, K
    Hafstaatter, M
    Hopner, S
    Ruckerl, D
    Soderhall, A
    Marin-Esteban, T
    Kuhne, R
    Freund, C
    Jung, G
    Falk, K
    Rotzschke, O
    CLINICAL IMMUNOLOGY, 2005, 115 : S221 - S221
  • [43] Allele-specific inhibition of HLA sequencing using peptide nucleic acids (PNA)
    Paul, P
    Jurcago, R
    Schatz, H
    Cook, D
    Ball, E
    HUMAN IMMUNOLOGY, 2005, 66 : S109 - S109
  • [44] Allele-Specific Cytokine Responses at the HLA-C Locus: Implications for Psoriasis
    Hundhausen, Christian
    Bertoni, Anna
    Mak, Rose K.
    Botti, Elisabetta
    Di Meglio, Paola
    Clop, Alex
    Laggner, Ute
    Chimenti, Sergio
    Hayday, Adrian C.
    Barker, Jonathan N.
    Trembath, Richard C.
    Capon, Francesca
    Nestle, Frank O.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2012, 132 (03) : 635 - 641
  • [45] IMPACT OF ALLELE-SPECIFIC ANTI-HLA ANTIBODIES ON ASSESSING IMMUNOLOGIC COMPATIBILITY
    Yin, Y.
    Takemura, P.
    Hickey, M.
    Sosa, R. A.
    Butler, C.
    Locke, A. F.
    Aguas, G.
    Zhang, Q.
    Reed, E. F.
    Valenzuela, N.
    HUMAN IMMUNOLOGY, 2022, 83 : 173 - 173
  • [46] DNA TYPING FOR CLASS-II HLA ANTIGENS WITH ALLELE-SPECIFIC OR GROUP-SPECIFIC AMPLIFICATION .4. TYPING FOR ALLELES OF THE HLA-DR2 GROUP
    MORAES, ME
    FERNANDEZVINA, M
    STASTNY, P
    HUMAN IMMUNOLOGY, 1991, 31 (02) : 139 - 144
  • [47] FUNCTIONAL-ANALYSIS OF DR17(DR3)-RESTRICTED MYCOBACTERIAL T-CELL EPITOPES REVEALS DR17-BINDING MOTIF AND ENABLES THE DESIGN OF ALLELE-SPECIFIC COMPETITOR PEPTIDES
    GELUK, A
    VANMEIJGAARDEN, KE
    JANSON, AAM
    DRIJFHOUT, JW
    MELOEN, RH
    DEVRIES, RRP
    OTTENHOFF, THM
    JOURNAL OF IMMUNOLOGY, 1992, 149 (09): : 2864 - 2871
  • [48] Quantification of Allele-Specific HLA Expression with Nanopore Long-Read Sequencing
    Hughes, Andrew E. O.
    Montgomery, Maureen C.
    Liu, Chang
    Weimer, Eric T.
    BLOOD, 2020, 136
  • [49] HLA-DP TYPING BY DNA AMPLIFICATION AND HYBRIDIZATION WITH ALLELE-SPECIFIC OLIGONUCLEOTIDES
    ANGELINI, G
    BUGAWAN, T
    DELFINO, L
    ERLICH, H
    FERRARA, GB
    HUMAN IMMUNOLOGY, 1988, 23 (02) : 77 - 77
  • [50] Correlation of allele-specific HLA loss of heterozygosity in patients with cancer with driver mutations
    Sewastianik, Tomasz
    Roy, Christian
    Halvey, Patrick
    Montesion, Meagan
    Jindal, Aastha
    Garrity, Sean
    Lam, Hubert
    Shapiro, Gary
    Vallaster, Markus P.
    Vincent, Loic
    Opiteck, Gregory
    Nagorsen, Dirk
    Klebanoff, Christopher Austin
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)